Stock screener
All disclosures →
EDGAR →
CRNX
Conviction 100HealthcareScan · Thu, Sep 24, 2026Crinetics Pharmaceuticals Inc (CRNX) closed at $84.95 (+0.13%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 90, RS Rating 99, at a 52-week high, +81.8% year to date. Sector: Healthcare · Biotechnology.
CRNX$84.95+0.13%
ResistanceSupportVol 14Insider sellCongress buyCongress sell2
Vol MA14 2.71M
Jun 2Jun 18Jul 9Jul 27Aug 13Aug 31
Price84.95
Change+0.13%
Gap+0.14%
Rel volume3.66×
Avg volume2.57M
Avg $ vol217.04M
SMA 2084.53
SMA 5074.83
SMA 20050.44
Price vs 50+13.52%
Price vs 200+68.41%
MA stackbullish
50/200 cross—
Supertrendup · 84.25
RSI (14)90
MACD hist-0.86
MACD cross—
Stoch %K / %D91 / 93
ADX (14)81
+DI / −DI59 / 5
RSI divergenceBearish
MACD divergence—
ATR %0.49%
ADR %0.20%
52w high84.95
52w low30.99
From 52w high+0.00%
Above 52w low+174.12%
New 52w highYes
SqueezeOff
Bollinger width1.61%
%B0.81
Donchian pos95.24%
Donchian high85.01
Donchian low83.75
AVWAP (52w high)84.96
vs AVWAP high-0.01%
AVWAP (52w low)60.02
vs AVWAP low+41.53%
OBV trendUp
Chaikin MF (20)-0.18
Today vs 20d3.66×
Avg vol (14d)2.71M
Avg vol (20d)2.57M
Avg $ vol (20d)217.04M
Market cap3.63B
RS Rating99 / 99
RS 3m (vs SPY)+144.97%
RS 6m (vs SPY)+97.07%
RS line new highNo
Trend template8/8
Technical rank93.9
1 week+0.20%
1 month+1.71%
3 months+146.09%
6 months+108.82%
1 year+177.16%
YTD+81.79%
P/E—
P/B—
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq—
Current—
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value—
Revenue—
Net income—
Gross profit—
Free cash flow—
IndustryBiotechnology
ExchangeXNAS
Shares out105.44M
Employees594
ListedWed, Jul 18, 2018
Free float100.71M
Float %95.5%
Short interest6.85M
Days to cover2.4d
Short volume—
Squeeze score51 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank93.9 / 100
Group rank—
Status laneNo active setup
Setup direction—
Pattern family
Resistance84.27
Support83.82
Days since event—
Candle confirm—
Congress activity
Disclosed STOCK Act trades in CRNX · 6 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
Gilbert Cisneros house · D · CA · traded 2026-07-30 | Sell | $15K–$50K | 2026-07-30 | 2026-09-04 | |
Gilbert Cisneros house · CA · traded 2026-03-03 | Buy | $1K–$15K | 2026-03-03 | 2026-04-06 | |
Gilbert Cisneros house · D · CA · traded 2025-04-17 | Buy | $1K–$15K | 2025-04-17 | 2025-05-06 | |
 Josh Gottheimer house · D · NJ · traded 2025-03-19 | Sell | $1K–$15K | 2025-03-19 | 2025-04-10 | |
Gilbert Cisneros house · D · CA · traded 2025-01-29 | Buy | $1K–$15K | 2025-01-29 | 2025-02-11 | |
Josh Gottheimer house · NJ · traded 2024-09-25 | Buy | $1K–$15K | 2024-09-25 | 2024-10-03 |
Insider activity
SEC Form 4 transactions in CRNX
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Bedrosian Camille L Director · Common Stock · 2026-09-01 | Disposition | 5.92K | $504K | 2026-09-01 | 2026-09-01 |
Bedrosian Camille L Director · Common Stock · 2026-09-01 | Disposition | 16.3K | $1.4M | 2026-09-01 | 2026-09-01 |
Bedrosian Camille L Director · Stock Option (Right to Buy) · 2026-09-01 | Disposition | 25K | $1.7M | 2026-09-01 | 2026-09-01 |
Bedrosian Camille L Director · Stock Option (Right to Buy) · 2026-09-01 | Disposition | 17.5K | $1.1M | 2026-09-01 | 2026-09-01 |
Bedrosian Camille L Director · Stock Option (Right to Buy) · 2026-09-01 | Disposition | 17.5K | $1.2M | 2026-09-01 | 2026-09-01 |
Bedrosian Camille L Director · Stock Option (Right to Buy) · 2026-09-01 | Disposition | 17.5K | $1.1M | 2026-09-01 | 2026-09-01 |
Bedrosian Camille L Director · Stock Option (Right to Buy) · 2026-09-01 | Disposition | 12.5K | $504K | 2026-09-01 | 2026-09-01 |
Bedrosian Camille L Director · Stock Option (Right to Buy) · 2026-09-01 | Disposition | 10.35K | $545K | 2026-09-01 | 2026-09-01 |
Bedrosian Camille L Director · Stock Option (Right to Buy) · 2026-09-01 | Disposition | 9.73K | $478K | 2026-09-01 | 2026-09-01 |
Betz Stephen F. Chief Scientific Officer · Common Stock · 2026-09-01 | Disposition | 58.29K | $5.0M | 2026-09-01 | 2026-09-01 |
SEC filings
EDGAR filings in CRNX · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.